| Contact |
General |
Specializations in Countries |
Contribution to the Global Plan |
Declaration |
View this partner's profile
Focal Point Contact Information |
| Salutation: |
Dr |
| First Name: |
Etienne |
| Last Name: |
Declercq |
| Title: |
Medical advisor to the Damien Foundation |
| Email: |
etienne.declercq@damien-foundation.be |
| Phone: |
32 2 422 59 14 |
|
Alternate Focal Point Contact Information |
| Salutation: |
Dr |
| First Name: |
Tine |
| Last Name: |
Demeulenaere |
| Title: |
Medical advisor to the Damien Foundation |
| Email: |
tine.demeulenaere@damien-foundation.be |
| Phone: |
32 2 422 59 37 |
|
General Information |
| Organization Type - Primary: |
Non-Governmental Organization |
| Organization Type - Secondary: |
Other Non-Governmental Organization (NGO) |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
| The Damien Foundation is a Belgian non-governmental organization whose primary objective is to support tuberculosis and leprosy control activities in endemic countries. The support given is both technical and financial. The Foundation gives priority to direct collaboration with national programmes. It also supports research projects concerning tuberculosis or leprosy. |
| |
| Total number of staff in your organization: |
11 - 25 |
| Number of full-time staff who are directly involved with TB: |
11 - 25 |
| Number of part-time staff who are directly involved with TB: |
100 + |
| Number of volunteers who are directly involved with TB: |
100 + |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: |
Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: |
Network with other partners |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| The Damien Fohundation is not involved in TB control in Belgium, but in 15 developing or mid-level countries in Africa, Asia and Latin America |
| |
Geographical Reach |
| Which country is your headquarters located in: |
Belgium |
| Which WHO region is the main focus of your work: |
Global |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
Bangladesh Brazil Burundi China Comoros Democratic Republic of the Congo Guatemala Guinea India Lao People's Democratic Republic Mozambique Nicaragua Niger Nigeria Rwanda |
Specializations |
Advocacy, communication and social mobilization Funding Provision of TB products TB Healthcare Services Technical Assistance |
Specializations in Countries |
| Advocacy, communication and social mobilization |
Bangladesh |
| Advocacy, communication and social mobilization |
Burundi |
| Advocacy, communication and social mobilization |
China |
| Advocacy, communication and social mobilization |
Comoros |
| Advocacy, communication and social mobilization |
Democratic Republic of the Congo |
| Advocacy, communication and social mobilization |
Guatemala |
| Advocacy, communication and social mobilization |
Guinea |
| Advocacy, communication and social mobilization |
India |
| Advocacy, communication and social mobilization |
Mozambique |
| Advocacy, communication and social mobilization |
Nicaragua |
| Advocacy, communication and social mobilization |
Niger |
| Advocacy, communication and social mobilization |
Nigeria |
| Advocacy, communication and social mobilization |
Rwanda |
| Funding |
Bangladesh |
| Funding |
Burundi |
| Funding |
China |
| Funding |
Comoros |
| Funding |
Democratic Republic of the Congo |
| Funding |
Guatemala |
| Funding |
Guinea |
| Funding |
India |
| Funding |
Lao People's Democratic Republic |
| Funding |
Mozambique |
| Funding |
Nicaragua |
| Funding |
Niger |
| Funding |
Nigeria |
| Funding |
Rwanda |
| Provision of TB products |
Bangladesh |
| Provision of TB products |
Burundi |
| Provision of TB products |
Comoros |
| Provision of TB products |
Democratic Republic of the Congo |
| Provision of TB products |
Guinea |
| Provision of TB products |
Niger |
| Provision of TB products |
Nigeria |
| TB Healthcare Services |
Bangladesh |
| TB Healthcare Services |
India |
| Technical Assistance |
Bangladesh |
| Technical Assistance |
Burundi |
| Technical Assistance |
China |
| Technical Assistance |
Comoros |
| Technical Assistance |
Democratic Republic of the Congo |
| Technical Assistance |
Guatemala |
| Technical Assistance |
Guinea |
| Technical Assistance |
India |
| Technical Assistance |
Lao People's Democratic Republic |
| Technical Assistance |
Mozambique |
| Technical Assistance |
Nicaragua |
| Technical Assistance |
Niger |
| Technical Assistance |
Nigeria |
| Technical Assistance |
Rwanda |
Contribution |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: |
DOTS Expansion and Enhancement: This is our first priority in all the 15 countries where the Damien Foundation is involved.
Drug-Resistant TB: DF suppoorts also the national programmes in that respect in all countries where we are involved. Special initiative has been taken in Bangladesh, in introducing in the DF projects a very successfull 9-month treatment regimen for MDR TB. Similar or slightly adapted regimens have also been introduced in other countries (Burundi, Niger). In the other countries, it is the 24-month WHO recommended regimen which is used.
TB-HIV: TB/HIV receives also much attention in all 15 counties, with special emphasis for Africa. This is done through stimulating collaboration between the TB and the HIV/AIDS Programmes, in order to offer : HIV testing to all TB patients (in Rwanda, also to TB suspects); regular TB screening for HIV patients; proper management of TB/HIV co-infection, through CPT and ARV (according to national policies); IPT for non-TB HIV patients.
Laboratory Strengthening: A system of external quality assurance for direct sputum microscopy has been introduced in all 15 countries where DF is present. LED microscopy is progressively introduced in some countries in high burden laboratories (DR Congo, Bangladesh, Burundi). Culture and DST is introduced in a number of countries or projects with the help of the Institute of Tropical Medicine, Antwerp (Bangladesh, DR Congo, Burundi, Rwanda, Niger, Nigeria, Guinea, India).
Operational Research: Some examples : short duration MDR TB treatment regimen in Bangladesh; collaboration with village doctors in Bangladesh, and with community volunteers in Burundi, for the identification of TB suspects and supervision of treatment; PAL in Nicaragua. |
Declaration |
Declaration of interests:
No conflict of interest
|
| Application date: |
|
| Last updated: |
May 24, 2012 |
|